Similar content being viewed by others
Article PDF
This article is cited by
-
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Signal Transduction and Targeted Therapy (2022)
-
Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor–binding protein-1 (HBp17/FGFBP-1)
In Vitro Cellular & Developmental Biology - Animal (2020)
-
Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism
Scientific Reports (2018)
-
Eldecalcitol (ED-71), an analog of 1α,25(OH)2D3, inhibits the growth of squamous cell carcinoma (SCC) cells in vitro and in vivo by down-regulating expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) and FGF-2
In Vitro Cellular & Developmental Biology - Animal (2017)
-
Up-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells
Scientific Reports (2016)